For weight management, NICE (TA664) recommends these medications within specialist weight management services for people with a BMI of at least 35 kg/m (or 32.5 kg/m in people from minority ethnic backgrounds) with non-diabetic hyperglycaemia and a high risk of cardiovascular disease, or a BMI of at least 30 kg/m with type 2 diabetes
Subsequently, analysis of covariance (ANCOVA) was conducted to examine the effects of diagnosis on Glu, Gln, and GABA levels in each VOI, with age and sex included as covariates
Even when medical intervention is needed, treatments are available that can help you achieve your goal of fatherhood
Injectable administration bypasses gut enzymes and first-pass metabolism, enabling more predictable pharmacokinetics
It is primarily known for its role in maintaining glucose balance in the body
In contrast, short-acting formulations such as exenatide and the older-generation agent lixisenatide are now prescribed far less frequently, and several formulations have been withdrawn from the market in certain countries, largely due to limited clinical uptake, the availability of more effective long-acting alternatives, and commercial considerations rather than confirmed safety concerns
